Cocrystal Pharma, Inc.
COCPNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for COCP. That does not mean none is planned.
Get an email about COCP's next catalysts
Track Cocrystal Pharma (COCP) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 1 past
COCP Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.17 | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Cocrystal Pharma, Inc.'s drug pipeline?→
CatalystAlert tracks 4 drug candidates in Cocrystal Pharma, Inc.'s (COCP) pipeline across Phase 2. Its lead program is CDI-988 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Cocrystal Pharma, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Cocrystal Pharma, Inc. (COCP) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track COCP biotech catalysts?→
Add COCP to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Cocrystal Pharma, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.